ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Nexus Pharmaceuticals, LLC

Official 2024 U.S. DOL Form 5500 summary for Nexus Pharmaceuticals, LLC (Nexus Pharmaceuticals, LLC 401(k) And Profit Sharing Plan · EIN 20-0324645 · PN 001): $12.33M net assets, 94 active participants, and $46.86 per $10,000 (46.86 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorNexus Pharmaceuticals, LLC
Filing IdentifierNexus Pharmaceuticals, LLC 401(k) And Profit Sharing Plan · EIN 20-0324645 · PN 001
Plan Category & State401(k) Defined Contribution (IL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$12.33M
Active Participants94
Direct Admin Fee Rate$46.86 per $10,000 (46.86 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderBank of America / Merrill
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI